Skip to content
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)

Ligand Pharmaceuticals Incorporated LGND and Channel Therapeutics Corporation CHRO on Thursday signed a definitive merger agreement to combine Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. (collectively Pelthos) with CHRO Merger Sub Inc.,… EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)

Trump Administration Asks IRS To Revoke Harvard’s Tax-Exempt Status After President Accuses Ivy League University Of Pushing ‘Sickness’

Trump Administration Asks IRS To Revoke Harvard’s Tax-Exempt Status After President Accuses Ivy League University Of Pushing ‘Sickness’

The Trump administration has requested that the Internal Revenue Service (IRS) to strip Harvard University of its tax-exempt status. This request was made on Wednesday, following a suggestion by President Donald Trump. What Happened: The inquiry was directed to Andrew… Trump Administration Asks IRS To Revoke Harvard’s Tax-Exempt Status After President Accuses Ivy League University Of Pushing ‘Sickness’